| Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium K Marder, Y Wang, RN Alcalay, H Mejia-Santana, MX Tang, A Lee, ... Neurology 85 (1), 89-95, 2015 | 163 | 2015 |
| Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations RN Alcalay, A Mirelman, R Saunders‐Pullman, MX Tang, ... Movement Disorders 28 (14), 1966-1971, 2013 | 138 | 2013 |
| Progression in the LRRK2-associated Parkinson disease population R Saunders-Pullman, A Mirelman, RN Alcalay, C Wang, RA Ortega, ... JAMA neurology 75 (3), 312-319, 2018 | 120 | 2018 |
| Digitized spiral drawing: A possible biomarker for early Parkinson’s disease M San Luciano, C Wang, RA Ortega, Q Yu, S Boschung, J Soto-Valencia, ... PloS one 11 (10), e0162799, 2016 | 104 | 2016 |
| Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance M San Luciano, CM Tanner, C Meng, C Marras, SM Goldman, AE Lang, ... Movement Disorders 35 (10), 1755-1764, 2020 | 69 | 2020 |
| Neuropsychiatric characteristics of GBA-associated Parkinson disease M Swan, N Doan, RA Ortega, M Barrett, W Nichols, L Ozelius, ... Journal of the neurological sciences 370, 63-69, 2016 | 57 | 2016 |
| Glucocerebrosidase enzyme activity in GBA mutation Parkinson’s disease RA Ortega, PA Torres, M Swan, W Nichols, S Boschung, D Raymond, ... Journal of clinical neuroscience 28, 185-186, 2016 | 56 | 2016 |
| Association of dual LRRK2 G2019S and GBA variations with Parkinson disease progression RA Ortega, C Wang, D Raymond, N Bryant, CR Scherzer, A Thaler, ... JAMA network open 4 (4), e215845-e215845, 2021 | 45 | 2021 |
| Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐Mennonites R Saunders‐Pullman, T Fuchs, M San Luciano, D Raymond, A Brashear, ... Movement Disorders 29 (6), 812-818, 2014 | 44 | 2014 |
| REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers R Saunders‐Pullman, RN Alcalay, A Mirelman, C Wang, MS Luciano, ... Movement Disorders 30 (13), 1834-1839, 2015 | 39 | 2015 |
| Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker? R Saunders‐Pullman, A Mirelman, C Wang, RN Alcalay, M San Luciano, ... Annals of clinical and translational neurology 1 (9), 670-678, 2014 | 38 | 2014 |
| Sex differences in LRRK2 G2019S and idiopathic Parkinson's disease M San Luciano, C Wang, RA Ortega, N Giladi, K Marder, S Bressman, ... Annals of clinical and translational neurology 4 (11), 801-810, 2017 | 32 | 2017 |
| Increased variability in spiral drawing in patients with functional (psychogenic) tremor CW Hess, AW Hsu, Q Yu, R Ortega, SL Pullman Human movement science 38, 15-22, 2014 | 30 | 2014 |
| Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls I Agalliu, RA Ortega, MS Luciano, A Mirelman, C Pont‐Sunyer, ... Movement Disorders 34 (9), 1392-1398, 2019 | 28 | 2019 |
| Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells E Navarro, E Udine, KP Lopes, M Parks, G Riboldi, BM Schilder, ... Nature aging 1 (9), 850-863, 2021 | 22 | 2021 |
| Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers EE Moran, SB Bressman, RA Ortega, D Raymond, WC Nichols, ... Frontiers in Neurology 12, 635958, 2021 | 16 | 2021 |
| DMS as an orthogonal separation to LC/ESI/MS/MS for quantifying isomeric cerebrosides in plasma and cerebrospinal fluid [S] H Xu, FR Boucher, TT Nguyen, GP Taylor, JJ Tomlinson, RA Ortega, ... Journal of Lipid Research 60 (1), 200-211, 2019 | 16 | 2019 |
| Differences in sex‐specific frequency of Glucocerebrosidase variant carriers and familial parkinsonism RA Ortega, SB Bressman, D Raymond, LJ Ozelius, V Katsnelson, ... Movement Disorders 37 (11), 2217-2225, 2022 | 12 | 2022 |
| Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers EE Moran, C Wang, M Katz, L Ozelius, A Schwartz, J Pavlovic, RA Ortega, ... Neurobiology of aging 58, 239. e1-239. e7, 2017 | 8 | 2017 |
| Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease K Leaver, A Viser, BH Kopell, RA Ortega, J Miravite, MS Okun, S Elango, ... Journal of neurosurgery 137 (1), 184-191, 2021 | 5 | 2021 |
